SSTR1 and renal cell carcinoma: One preliminary study (Sun et al., 2021) confirmed that SSTR1 is a target gene affecting renal cell carcinoma (RCC) metastasis and the associated immune response and could be a prognostic biological marker of and viable therapeutic target for RCC.